4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-013170
CHAIRMAN & CEO sold 2,872 shares at $27.03 ($77,630)
- CHAIRMAN & CEO acquired 2,872 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2025-05-13 | Option exercise 10b5-1 | +2,872 | $1.59 | $4,566 | 99,546 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-13 | Sale 10b5-1 | −2,872 | $27.03 | $77,630 | 96,674 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-13 | Option exercise · Share Option 10b5-1 | −2,872 | 88,619 | D | ||
| Open-market sales · 2,872 sh · avg $27.03 · $77,630 | |||||||
Loading xslF345X05/form4-05152025_080533.xml…